[ET Net News Agency, 29 August 2019] Innovent Biologics, Inc. (01801) said its loss was
RMB714.41 million for the six months ended 30 June 2019, compared to the profit of
RMB43.89 million of the same period last year. The loss per share was RMB0.62. No dividend
will be distributed.
The revenue from contracts with customers was RMB345.52 million, a year-on-year increase
of 76.89 times. (RC)